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The adipose-derived stromal vascular fraction (SVF) represents a rich source of mesenchymal cells, potentially
able to differentiate into adipocytes, chondrocytes, osteoblasts, myocytes, cardiomyocytes, hepatocytes, and
neuronal, epithelial, and endothelial cells. These cells are ideal candidates for use in regenerative medicine, tissue
engineering, including gene therapy, and cell replacement cancer therapies. In this work, we aimed to the
optimization of the adipose SVF-based therapy, and the effect of the collection site, surgical procedure, and
tissue processing techniques on SVF yield was evaluated in terms of cell recovery and live cells, taking into
account the effect of gender, age, and body mass index. Adipose tissue samples were recovered from 125
informed subjects (37 males and 88 females; mean age: 51.31 years; range: 15–87 years), and digested in different
condition with collagenase. A multivariate linear model put in evidence that in males the best collection site in
terms of yield is located in the abdomen, whereas in females the biopsy region do not influence cell recovery; the
collection technique, the age, and the body mass index of donor seem not to influence the cell yield. The tissue-
processing procedures strongly modify the yield and the vitality of cells: a collagenase concentration of 0.2% and
a digestion time of 1 h could be chosen as the best operating conditions.
Introduction
Adipose tissue has traditionally been considered asa virtually inert tissue until the mid-1990s with the
discovery of leptin and adiponectin that ‘‘led to a major re-
naissance in this field’’1; now, the evidence that the autolo-
gous fat transplantation can be exploited for tissue
regeneration has come to the fore.2–7 In fact, adipose tissue
has been identified as a rich, easy-to-reach source of
mesenchymal stem cells (MSCs), able to differentiate into
adipocytes, chondrocytes, osteoblasts, myocytes, cardio-
myocytes, hepatocytes, epithelial cells, and endothelial
cells.8–11 Some authors report that also neuronal/glial dif-
ferentiation can occur from the morphological but not
physiological point of view.12,13
Besides, many authors describe MSCs as cells endowed of
neoangiogenic, immunomodulatory, antiinflammatory,14–18
and putative antineoplastic19–22 properties, and possibly
employable in a plethora of degenerative pathologies. Adi-
pose tissue is composed of two main cell populations, ma-
ture adipocytes and stromal vascular fraction (SVF): the
latest is an heterogeneous fraction including preadipocytes,
endothelial cells, smooth muscle cells, pericytes, macro-
phages, fibroblasts,23–25 and adipose-derived stem cells
(ADSCs),9,10,24,26–33 which share several characteristics with
bone marrow stem cells.34
Because of their stemness properties as self-renewal ca-
pacity, long-term viability, and multilineage potential, the
employ of ADSCs is proposed in tissue engineering and re-
generative medicine6; moreover, the use of SVF or ADSCs
has been proposed in several chronic pathologies as Crohn
disease,35 graft-versus-host disease,36 autoimmune patholo-
gies (e.g., multiple sclerosis),15 and allergic pathologies37: the
therapeutic approach toward these pathologies can be ex-
plained by the immunoregulatory and antiinflammatory
activities of ADSCs or nonexpanded SVF cells.15 In 2010
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Caplan38 proposed an intriguing mechanism that contribute
to establish a regenerative microenvironment: after an injury,
the pericytes adjacent to blood vessels activate MSCs, which
in turn secrete bioactive molecules as immunomodulators,
and trophic, antiapoptotic, antiscarring, angiogenic, and
mitotic factors. In these perspectives, the widespread employ
of MSCs in several pathologies could be explained: MSCs can
be viewed as ‘‘site-regulated drug stores,’’ and renominated
‘‘medicinal signaling cells’’ instead of ‘‘mesenchymal stem
cells.’’ For the clinical employ of MSCs in cell therapy, dif-
ferent approaches can be followed: as for a drug, adminis-
tration of MSCs can be performed either by systemic
intravascular perfusion or by in situ delivery. Moreover,
either native, nonexpanded cells or in vitro expanded/
differentiated cells can be employed. Once recovered, stem
cells are separated from their natural niche; therefore, the
physiological microenvironmental conditions during culture
are altered. It is mandatory to explain the number of signals
that regulate cells behavior when into their niche, aiming to
maintain an undifferentiated stage when cultured.39 On the
other hand, Rubio et al.40 have shown that human ADSCs
undergo malignant transformation with prolonged passag-
ing over >4 months; however, in this study the number of
passages is not reported because of limitations in estimating
the number of cell divisions.
Some authors6,15,41 consider the use of freshly isolated
nonexpanded cells as safer and more practical. For this
purpose, the number of recovered cells must be sufficiently
high to reach the therapeutic dosage: the most promising
tissue for the recovery of MSCs is the subcutaneous white
adipose tissue. Adipose tissue cell population can greatly
differ depending on of harvesting site, age, gender, and body
mass index (BMI); this feature leaves intriguing questions, as
reported by Gimble et al.7: ‘‘Although studies are limited,
adipose depot specific differences appear to exist with re-
spect to stem cell content. […] It remains to be determined as
to which human adipose tissue depot should be harvested
for optimal stem cell recovery.’’ Some research oriented to-
ward the effect of age, gender, and anatomical region on
osteogenic differentiation of ADSCs.42,43 Recent advances
support the theory that all MSCs are pericytes localized in
ablumenal surface of blood vessels.44 If MSCs are located in
the adipose perivascular niche, the degree of vascularization
strongly influences the number of MSCs recovered from dif-
ferent sites, as reported by da Silva Meirelles et al.45 and by da
Silva Meirelles et al.46 Indeed, both immunomodulatory and
trophic effects, considered as powerful therapeutic agents,
seem not to be related to the differentiation properties.38
Moreover, the surgical procedure to obtain adipose tissue
and the subsequent treatment can heavily influence the
properties of SVF and ADSC vitality and yield.
In this work, we aimed to the optimization of the SVF-
based therapy, and the effect of the collection site, surgical
procedure, and tissue processing techniques on SVF yield
was evaluated in terms of cell recovery and viability, taking
into account the effect of gender, age, and BMI.
Materials and Methods
Subjects
In total, 125 informed subjects (37 males and 88 females;
mean age: 51.31 years; range: 15–87 years) were enrolled.
Tissue sampling and use was approved by the competent
ethics committee. Age did not differ between genders (males:
51.67 18.69; females: 51.15 18.63; t¼ 0.146, p¼ 0.88), as
well as the BMI (males: 25.33 3.44; females: 26.68 5.40;
t¼ 1.588, p¼ 0.116). Adipose tissue was obtained as waste
material after elective surgery by liposuction or manual re-
section. During esthetic plastic surgery, fat samples were
manually harvested by liposuction of subcutaneous fat tis-
sue, by negative pressure using a 10-mL syringe, with a blunt
tip cannula and processed following Coleman’s technique.47
Resected fat samples were obtained by exeresis using a
scalpel from herniated disc standard discectomy surgery,
meniscectomy, or reductive mastoplasty. No cauteries were
employed. By comparing the surgical techniques, male pa-
tients were submitted to resection more frequently than fe-
males (86.5% vs. 51.1%, respectively; w2¼ 13.8, p< 0.001).
Harvesting sites were differently distributed for males and
females: male donors gave samples from back (herniation,
70.3%), abdomen (abdominoplasty, 13.5%), and knee (me-
niscectomy, 16.2%), whereas females from back (herniation,
13.6%), abdomen (abdominoplasty, 30.7%), breast (reductive
mastoplasty, 14.8%), and thigh (liposculture, 11.4%). The
2.2% of collections regarded resections from the neck zone.
Clinical sheets of patients (identity, gender, age, tissue-
processing laboratories, sampling site, day of collection, and
anamnesis) are filed by the structure responsible of the surgery.
From the trial were excluded patients with septicemia or
extensive infections, syphilis, type B and C hepatitis, HIV,
Creutzfeld-Jacobs disease, viral or unknown neurological
diseases, human GH treatment, dural treatment, and ma-
lignant tumors.
Cell isolation
Procedures were conducted in a cleaning room (Class B,
GMP guidelines). Each suite is supported by single-pass,
positive-pressure (60 Pa), HEPA-filtered air, at a temperature
of 188C and relative humidity 50%. The flow suite is unidi-
rectional, with entry and exit air locks. The cleaning room
environment was monitored by wireless probes directly in-
terfaced with an external computer to assure the same op-
erating conditions during each process step, as required by
the European Community Guidelines that rule for the
product in advanced therapies. Low contamination levels
were guaranteed by differential pressures, absolute filtration
systems, and unidirectional laminar air flow. Personnel were
trained in respect of the GMP guidelines. All the steps were
conducted in certified ISO Class 5 (Class 100) laminar flow
biosafety cabinets. Environmental cleanliness controls were
performed before operation in the unmanned state (t0), and
in the manned state during normal use (t1). Particulate
contamination control tests were conducted on the air sam-
ple (determination of CFU/m3 air) using sedimentation settle
plates (CFU/4 h), agar contact plates (CFU/plate), and the
operator’s gloved hand test.
In the operating room adipose samples were suspended in
phosphate-buffered saline (PBS) with penicillin/streptomycin
1%, put into a sterile box, and forwarded to a GMP lab-
oratory at the temperature of 48C. Adipose tissue samples
were digested using collagenase in PBS without calcium/
magnesium plus penicillin 100 IU/mL and streptomycin
100 mg/mL at 378C. Two collagenase from two different
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suppliers were employed (Serva or Sigma-Aldrich), and
different collagenase concentration (ranging from 0.05% to
0.20%) were employed for different incubation times (rang-
ing from 1 to 12 h). The different digestion protocols were (a)
0.05% collagenase, incubation 12 h; (b) 0.075% collagenase,
incubation 12 h; (c) 0.10% collagenase, incubation 2 h; (d)
0.15% collagenase, incubation 1 h; and (e) 0.20% collagenase,
incubation 1 h. Mature adipocytes and connective tissues
were separated from SVF by centrifugation as reported by
Zuk et al.48 After centrifugation, cells were washed twice
with PBS to obtain clean pellets.
Cellular yield was calculated as the number of stromal
cells obtained per milliliter of bioptical tissue; counts were
performed after staining with Trypan Blue in a Bu¨rker
chamber. In each sample the vitality and vital cell yield (live
cells/mL treated tissue) were calculated. All samples were
counted in triplicate.
Morphological investigation
Tissue digestion processes were monitored using cytospin
centrifuge: slides and filters were placed into appropriate
slots. Then, aliquots of 100mL of each sample were centri-
fuged for 5 min with a rotation of 700 rpm. Slides were first
treated with paraformaldehyde 4% for 15 min and subse-
quently with PBS 1% for 5 min. Then, they underwent a 10%
May-Grunwald Giemsa staining for 10 min.
Statistical analyses
To evaluate the effect of subject characteristics, the col-
lection techniques and tissue procedures on cell yield, vital-
ity, and live cell yield, a linear multiple regression analysis
was applied. As independent variables, the following subject
characteristics were taken into account: gender, BMI, and
age; the surgical techniques: resection or aspiration; collec-
tion site: abdomen, thigh, neck, back, breast, and knee; tissue
processing conditions: (a) 0.05% collagenase, incubation 12 h;
(b) 0.075% collagenase, incubation 12 h; (c) 0.10% collage-
nase, incubation 2 h; (d) 0.15% collagenase, incubation 1 h;
and (e) 0.20% collagenase, incubation 1 h; digestion depth:
total, partial, and undigested. Since vitality did not fit the
model, a univariate nonparametric analysis was performed:
for each independent variable, the tests of Mann–Whitney or
Kruskal–Wallis were applied. Significance level was set at
a¼ 0.05.
Results
By employing the Zuk procedure,48,49 samples of SVF cells
were obtained. After the first 30 min of adipose tissue di-
gestion, with collagenase concentration 0.2% (Fig. 1a), the
samples appeared partially digested, whereas SVF was iso-
lated from the extracellular matrix after 1 h (Fig. 1b).
The results of SVF yield and live cell yield are reported in
Table 1 as a function of gender and surgical technique. Sta-
tistical differences between average values ( p< 0.05) were
found only for yield and live cell yield, and a significant
interaction was evidenced between gender and surgical
technique (data not shown): in fact, male subjects were not
treated with liposuction surgical technique. The significant
interaction implies that possible gender and/or surgical
technique differences cannot be seen as separated factors. For
these reasons the linear multivariate model was applied by
stratifying by gender. The linear model results are reported
in Table 2. Cell and live cell yields (in females) were not
influenced by the surgical technique, whereas different yield
were obtained in different collection sites in male subjects:
the higher cell and live cell yield were obtained when cells
were recovered from the abdomen with respect to the back
( p¼ 0.001) and to the knee ( p< 0.02). In females, no signif-
icant differences were found between collection site and
cellular yield (Table 2). Digestion was performed with col-
lagenase purchased from two suppliers: no differences were
found in both cell yield and live cell yield (Table 2). Digestion
conditions indeed significantly influenced both cell and live
cell yield: in tissue sampled from male subjects, digestion
with collagenase 0.2% per 1 h incubation gave the best results
and was taken into account as reference. By reducing the
collagenase concentration to 0.15%, incubation 1 h (treatment
d), the cell and live cell yield decreased in a significant way
( p< 0.02). Digestion with 0.1% collagenase (treatment c) did
not increase yields after 2 h of incubation. The 12 h overnight
digestion with (treatment a) 0.05% collagenase and (b)
0.075% collagenase reduced both cell yield and live cell yield
( p< 0.05 in treatment a). In females, overnight treatment
(treatment b) gave higher yield ( p< 0.001) with respect to
treatment (e) on both of the response variables. Neither in
males nor in females BMI and age influenced any of the
response variables. Adjusted determination coefficients for
the model were higher in the male stratum than in the female
one (Table 2).
Discussion
ADSCs are promising candidates in a broad range of in-
novative therapies, ranging from regenerative medicine to
tissue engineering, in autoimmune pathologies or chronic
flogosis: clearly, different cell types should be employed
in different clinical situations. SVF is the starting point, for
example, the raw material necessary to realize products for
FIG. 1. Microphotograph of
digested adipose tissue (col-
lagenase 0.2%) after 300 (a) and
after 1 h (b). May-Grunwald-
Giemsa staining. Color images
available online at www
.liebertonline.com/ten.
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Table 1. Average Values and Dispersion Indices for Yield, Live Cell Yield, and Vitality Stratified
for Gender and Surgical Technique
Factor n Yield (log-million)a Live cell yield (log-million)a Vitality %b
Male 36 1.44 1.62 1.05 0.78 77 (67–87)
Female 78 2.05 1.46 1.80 1.52 81 (72–88)
t¼ 2.00, p¼ 0.048 t¼2.33, p¼ 0.022 MW¼1.07, p¼ 0.283
Resection 68 1.39 1.50 1.05 1.61 78.5 (70–87)
Aspiration 46 2.56 1.32 2.33 1.38 82 (73–88)
t¼4.27, p< 0.0001 t¼4.39, p< 0.0001 MW¼1.53, p¼ 0.127
Yield and live cell yield are log-transformed.
aMean standard deviation.
bMedian and interquartile range.
t, t-test; MW, Mann–Whitney test.
Table 2. Effect of Surgical Technique, Collection Site, Type of Collagenase, Digestion Conditions,
Digestion Result, Body Mass Index, and Patient’s Age on Cell Yield and on Live Cell Yield
Male Female
MR t-Value p-Value CI 95% MR MR t-Value p-Value CI 95% MR
Cell yield
Surgical technique
Resection/liposuction — — — — — 0.418 1.48 0.146 0.123 1.368
Collection site
Thigh/abdomen — — — — — 3.657 1.75 0.086 0.872 16.169
Back/abdomen 0.057 3.61 0.001 0.011 0.294 0.672 0.48 0.631 0.129 3.492
Breast/abdomen — — — — — 0.419 1.72 0.091 0.152 1.156
Knee/abdomen 0.037 2.54 0.018 0.002 0.541 0.812 0.24 0.813 0.140 4.714
Type of collagenase
Sigma/Serva — — — — — 0.940 0.05 0.963 0.065 13.567
Digestion conditionsa
a/e 0.041 2.15 0.042 0.002 0.881 — — — — —
b/e 0.154 1.59 0.126 0.013 1.763 8.878 4.30 <0.001 3.204 24.6
c/e 0.286 0.82 0.422 0.012 6.791 — — — — —
d/e 0.031 2.90 0.008 0.003 0.370 — — — — —
Digestion result
Partial/complete 1.616 0.52 0.608 0.239 10.917 0.403 0.95 0.348 0.059 2.756
BMI 1.131 1.34 0.192 0.936 1.366 0.975 0.74 0.462 0.909 1.045
Age 1.014 1.02 0.319 0.986 1.042 0.982 1.33 0.188 0.955 1.009
Adjusted determination coefficient 0.51 0.35
Live cell yield
Surgical technique
Resection/liposuction — — — — — 0.373 1.62 0.112 0.110 1.267
Collection site
Thigh/abdomen — — — — — 3.915 1.79 0.080 0.846 18.121
Back/abdomen 0.024 3.98 0.001 0.003 0.168 0.618 0.57 0.572 0.113 3.377
Breast/abdomen — — — — — 0.389 1.81 0.076 0.137 1.109
Knee/abdomen 0.018 2.63 0.015 0.001 0.422 0.850 0.18 0.858 0.139 5.208
Type of collagenase
Sigma/Serva — — — — — 1.087 0.06 0.952 0.069 17.021
Digestion conditionsa
a/e 0.022 2.19 0.039 0.001 0.815 — — — — —
b/e 0.089 1.74 0.095 0.005 1.574 9.998 4.40 <0.001 3.497 28.589
c/e 0.361 0.56 0.578 0.009 15.106 — — — — —
d/e 0.030 2.50 0.020 0.002 0.548 — — — — —
Digestion result
Partial/complete 1.402 0.31 0.759 0.147 13.349 0.289 1.26 0.214 0.040 2.093
BMI 1.223 1.87 0.074 0.979 1.529 0.969 0.87 0.388 0.902 1.041
Age 1.020 1.24 0.229 0.987 1.053 0.981 1.36 0.181 0.953 1.009
Adjusted determination coefficient 0.43 0.36
Results are stratified by gender. Mean ratios (MR), 95% confidence intervals of mean ratios (CI 95% MR), and statistical tests are reported.
a(a) 0.05% collagenase, incubation 12 h; (b) 0.075% collagenase, incubation 12 h; (c) 0.10% collagenase, incubation 2 h; (d) 0.15% collagenase,
incubation 1 h; and (e) 0.20% collagenase, incubation 1 h.
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advanced therapy. SVF can be employed just after retrieval
without cell type selection; otherwise, ADSCs can be isolated
and expanded, after plating and culture in selected media. In
any case, cells must be retrieved in a sufficient number to
reach the therapeutic dosage and this is a constant trouble.
Expansion of extracted cells could be a solution, but a high
number of passages could modificate cells toward poten-
tially tumorigenic cell lineages. After the seminal works by
Zuk et al.48 since 2001, a number of independent research
groups retrieved MSCs from adipose tissue samples by col-
lagenase digestion: the preliminary step was to consolidate
this procedure in a relatively high sample size defining the
optimal operative conditions (time and collagenase concen-
tration) to obtain the best cell yield.
Liposuction aspirates are already employed in several
clinical trials, but the articles on the optimization of isolation
techniques and product characterization are scarce. In this
perspective, the use of minimally manipulated fresh cells
may lead to higher safety and efficacy in actual treatments.
In this article the effect of the collection site, surgical
procedure, and tissue-processing techniques on SVF yield
was evaluated in terms of cell recovery and viability, taking
into account the effect of gender, age, and BMI. Since it was
impossible to enroll male donors undergoing liposuction
esthetical intervention, the interaction between gender and
surgical technique was predictable: to overcome that pitfall,
the linear multivariate model was applied by stratifying by
gender. To better define the relations between these vari-
ables, it could be desirable to include lipoaspirated tissues
from male donors. Results suggest that the effect of age and
BMI are not significant, whereas the digestion conditions and
the collection site have a significant effect on the output
variables in both genders. In males, the best digestion con-
ditions are set at 0.2% collagenase (1 h incubation), and in
females the higher yields are reached with overnight diges-
tion. This behavior could be due to the differences in the
fibrous matrix of adipose tissue in male and female subjects.
Gender-related differences between adipose tissue have been
widely studied by several authors43: in the present work, a
significant gender effect has not been fully verified, due to
interaction with surgical technique, and these effects there-
fore cannot be considered separately.
Viability can be influenced by tissue processing (collage-
nase concentration and digestion timing), as reported by
Bakker et al.50: in this work, the lack of significance in vitality
between groups could be due to the digestion conditions that
do not compromise cell vitality.
In 2004, Bakker et al.50 on obese to heavily obese indi-
viduals did not find any association in BMI, age, and pre-
adipocyte recovery from adipose tissue, whereas they
observed large differences between subcutaneous and
omental tissue and isolation protocol. The results presented
in this article agree with those previously obtained by Bakker
et al., although these researchers were interested to the pre-
adipocyte in a different context.
von Heimburg et al.51 observed that if cell isolation is not
performed soon after the operation, liposuction material is
the better alternative for preadipocyte recovery if compared
with resection. Oedayrajsingh-Varma et al.52 report that ad-
ipose-tissue-collecting procedures and SVF isolation meth-
ods seem to influence the yield, viability, and replication
potential of the recovered cells: the resection gave better
yield results than lipoaspiration in terms of SVF yield results
(almost 3% higher).
Van Harmelen et al.53 demonstrated that there were no
apparently significant differences between males and fe-
males involved in this study in terms of BMI, age, number of
SVF cells obtained per gram of omental and subcutaneous
adipose tissue starting volume, and proliferation potential of
the SVF populations recovered.
In 2003, the same research group,54 considering 189 fe-
males undergoing surgical mammary reduction, concluded
that BMI correlated positively to age, mature fat cell size, and
total number of adipocytes and stromal cells per body.
Anyway this study also reports that BMI correlated nega-
tively to the capacity of SVF cells to differentiate: the obese
subjects showed larger stromal and fat cell numbers com-
pared to lean subjects, but, at the same time, SVF cells were
characterized by a lesser capacity to undergo adipogenic
differentiation. Age did not correlate either to the number of
stromal cells per gram of adipose tissue or to the differenti-
ation potential of SVF recovered. Similar results were re-
ported by Aust et al.55: it was estimated that, considering
a 87.5% female population (n¼ 18) with a mean age
(standard deviation) of 44 10 years and BMI of 24.9 2.7,
the mean SVF cell yield was 404.000 206.000 cells/mL of
lipoaspirate. Linear regression analysis of the cells derived
from the female donors demonstrated a significant nega-
tive correlation between the number of cells obtained per mil-
liliter of lipoaspirate with the BMI but not the age of the donor.
Differences in terms of SVF yield and viability can be
correlated to the subcutaneous body site from which such
cells are recovered. Hauner and Entermann56 demon-
strated that regional differences exist in the capacity of
recovered SVF to form new fat cells when they are re-
covered from the abdominal rather than femoral adipose
tissue depots. Such variability was noted even when the
SVF was recovered from abdominal rather than hip sub-
cutaneous depots of adipose tissue24: in this case, beside
noticing that tissue harvested from the hip yielded 2.3-fold
more CFU-F/unit volume and a 7-fold higher frequency
of differentiation than that obtained from the abdomen,
donor-to-donor variation in stem cell recovery was even
reported.
In summary, in males the best collection site in terms of
yield is located in the abdomen, whereas in females the bi-
opsy region do not influence cell recovery; the collection
technique, the age, and the BMI of donor seem not to influ-
ence the cell yield. The tissue-processing procedures strongly
modify the yield and the vitality of cells: a collagenase con-
centration of 0.2% and a digestion time of 1 h could be cho-
sen as the best operating conditions.
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